Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02729922 · ClinicalTrials.gov registry record
Registry of Patients With CardioMEMS
A clinical trial of Heart Failure, Congestive, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT02729922 is a study of Heart Failure, Congestive that has completed, run by University of Pennsylvania. The registered enrollment target is 30 participants, below the 641-participant average among 33 other Heart Failure, Congestive trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02729922, a study of Heart Failure, Congestive, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
CardioMEMS is an implantable wireless hemodynamic monitoring system which can transmit the pulmonary artery pressure. This device is FDA approved to be used as a diagnostic tool to help management of selected heart failure patients. Heart failure patients with NYHA class III heart failure, irrespective of the left ventricular ejection fraction, and a previous hospital admission for heart failure in the past 12 months, without stage IV or V chronic kidney disease are candidates to receive a CardioMEMS device. Our goal is to create a registry of all patients that receive a CardioMEMS device and monitor outcomes, primarily heart failure hospitalizations, heart failure related quality of life and re-admissions.
Conditions Studied
Interventions
- DEVICE Cardiomems
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-03 |
| Est. Completion | 2025-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02729922
The ClinicalTrials.gov registry entry for NCT02729922 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 641-participant average among 33 other Heart Failure, Congestive trials with a reported enrollment target (95% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure, Congestive appearing as the primary indexed condition, and to 1 intervention - of which Cardiomems is the first listed.
NCT02729922 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02729922 about?
NCT02729922 is a clinical study titled "Registry of Patients With CardioMEMS". CardioMEMS is an implantable wireless hemodynamic monitoring system which can transmit the pulmonary artery pressure. This device is FDA approved to be used as a diagnostic tool to help management of selected heart failure patients. Heart failure patients with NYHA class III heart failure, irrespect...
What is the current status of trial NCT02729922?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2016-03. Estimated completion is 2025-06.
What conditions does trial NCT02729922 study?
This clinical trial studies the following conditions: Heart Failure, Congestive.
What interventions are being tested in trial NCT02729922?
The interventions under investigation include: Cardiomems (DEVICE).
Who is sponsoring clinical trial NCT02729922?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02729922 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure, Congestive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
RECRUITING
-
Magnetic Resonance Spectroscopy Studies of Cardiac Muscle Metabolism
RECRUITING
-
Diuretics vs. Afterload Reduction for Treatment of HeartLogic Alerts
RECRUITING · Phase 4
-
Comparison of Noninvasive vs. Invasive Hemodynamic Measurements
ACTIVE NOT RECRUITING
-
Cardiovascular Health Study (CHS)
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.